From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

Por Wahl, Richard L., Jacene, Heather, Kasamon, Yvette, Lodge, Martin A.
Publicado em 2009

Systemic Immune Response to Vaccination on FDG-PET/CT

Por Mingos, Mark, Howard, Stephanie, Giacalone, Nicholas, Kozono, David, Jacene, Heather
Publicado no Nucl Med Mol Imaging (2015)

Reproducibility of Tumor Blood Flow Quantification with (15)O-Water PET

Por Lodge, Martin A., Jacene, Heather A., Pili, Roberto, Wahl, Richard L.
Publicado em 2008

The Relationship between Patients’ Serum Glucose Levels and Metabolically Active Brown Adipose Tissue Detected by PET/CT

Por Jacene, Heather A., Cohade, Christian C., Zhang, Zhe, Wahl, Richard L.
Publicado no Mol Imaging Biol (2011)

Comparison of Residence Time Estimation Methods for Radioimmunotherapy Dosimetry and Treatment Planning—Monte Carlo Simulation Studies

Por He, Bin, Wahl, Richard L., Du, Yong, Sgouros, George, Jacene, Heather, Flinn, Ian, Frey, Eric C.
Publicado em 2008

Predicting Hematologic Toxicity in Patients Undergoing Radioimmunotherapy with (90)Y-Ibritumomab Tiuxetan or (131)I-Tositumomab

Por Baechler, Sébastien, Hobbs, Robert F., Jacene, Heather A., Bochud, François O., Wahl, Richard L., Sgouros, George
Publicado em 2010

Refractory myeloid sarcoma with a FIP1L1-PDGFRA rearrangement detected by clinical high throughput somatic sequencing

Por Mandelker, Diana, Dal Cin, Paola, Jacene, Heather A., Armand, Philippe, Stone, Richard M., Lindeman, Neal I.
Publicado no Exp Hematol Oncol (2015)

Evaluation of quantitative imaging methods for organ activity and residence time estimation using a population of phantoms having realistic variations in anatomy and uptake

Por He, Bin, Du, Yong, Segars, W. Paul, Wahl, Richard L., Sgouros, George, Jacene, Heather, Frey, Eric C.
Publicado em 2009

Arterial Wall Dosimetry for Non-Hodgkin Lymphoma Patients Treated with Radioimmunotherapy

Por Hobbs, Robert F., Baechler, Sébastien, Wahl, Richard L., He, Bin, Song, Hong, Esaias, Caroline E., Frey, Eric C., Jacene, Heather, Sgouros, George
Publicado em 2010

[(18)F]Fluorodeoxyglucose Positron Emission Tomography Correlates With Akt Pathway Activity but Is Not Predictive of Clinical Outcome During mTOR Inhibitor Therapy

Por Ma, Wen Wee, Jacene, Heather, Song, Dongweon, Vilardell, Felip, Messersmith, Wells A., Laheru, Dan, Wahl, Richard, Endres, Chris, Jimeno, Antonio, Pomper, Martin G., Hidalgo, Manuel
Publicado em 2009

Comparison of organ residence time estimation methods for radioimmunotherapy dosimetry and treatment planning—patient studies

Por He, Bin, Wahl, Richard L., Sgouros, George, Du, Yong, Jacene, Heather, Kasecamp, Wayne R., Flinn, Ian, Hammes, Richard J., Bianco, Jay, Kahl, Brad, Frey, Eric C.
Publicado em 2009

Phase I Trial of Oxaliplatin, Infusional 5-Fluorouracil, and Leucovorin (FOLFOX4) With Erlotinib and Bevacizumab in Colorectal Cancer

Por Messersmith, Wells A., Jimeno, Antonio, Jacene, Heather, Zhao, Ming, Kulesza, Piotr, Laheru, Daniel A., Kahn, Yasmin, Spira, Alexander, Dancey, Janet, Iacobuzio-Donahue, Christine, Donehower, Ross C., Carducci, Michael, Rudek, Michelle A., Hidalgo, Manuel
Publicado em 2010

Pharmacodynamic-Guided Modified Continuous Reassessment Method–Based, Dose-Finding Study of Rapamycin in Adult Patients With Solid Tumors

Por Jimeno, Antonio, Rudek, Michelle A., Kulesza, Peter, Ma, Wen Wee, Wheelhouse, Jenna, Howard, Anna, Khan, Yasmin, Zhao, Ming, Jacene, Heather, Messersmith, Wells A., Laheru, Daniel, Donehower, Ross C., Garrett-Mayer, Elizabeth, Baker, Sharyn D., Hidalgo, Manuel
Publicado em 2008

Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma

Por Kasamon, Yvette L., Jacene, Heather A., Gocke, Christopher D., Swinnen, Lode J., Gladstone, Douglas E., Perkins, Brandy, Link, Brian K., Popplewell, Leslie L., Habermann, Thomas M., Herman, Joseph M., Matsui, William H., Jones, Richard J., Ambinder, Richard F.
Publicado em 2012